The iBstone AuraLink is a mid-priced OTC hearing aid released in 2024, priced at $649. In HearAdvisor's lab testing, it achieved a SoundScore of 3.20 out of 5, placing it below the OTC category average of 3.46.
The AuraLink's performance profile is notably uneven. Its standout strength is music streaming, scoring 3.60—a full 1.83 points above the category average—making it one of the better options for users who prioritize audio entertainment. Feedback handling is also excellent at 5.00/5, meaning users experienced no audible feedback during standardized challenge testing.
However, the device struggles in core hearing aid functions. Speech in quiet measured 0.46 points below average, and speech in noise performance was particularly weak at 1.32 points below the category average. This suggests the AuraLink may not deliver adequate benefit in the conversational situations where most users need help most.
The iBstone AuraLink may suit users who prioritize music and media streaming over speech clarity, but those seeking improved conversation understanding should consider alternatives. Similar or better overall sound performance is available at lower prices—the iHear MatriX offers a higher SoundScore of 3.35 at $499, saving $150.
